PDUFA Negotiations Would Add Patient, Consumer Reps Under House Bill

The role of drug manufacturers in negotiating how FDA spends prescription drug user fees would be diminished under a draft user fee reauthorization bill prepared for markup in the House Energy and Commerce Committee's Health Subcommittee